(Chitosan-g-glycidyl methacrylate)-xanthan hydrogel implant in Wistar rats for spinal cord regeneration.

This work reports the results of in vivo assays of an implant composed of the hydrogel Chitosan-g-Glycidyl Methacrylate-Xanthan [(CTS-g-GMA)-X] in Wistar rats. Degradation kinetics of hydrogels was assessed by lysozyme assays. Wistar rats were subjected to laminectomy by cutting the spinal cord with a scalpel. After the surgical procedure, hydrogels were implanted in the injured zone (level T8). Somatosensory evoked potentials (SEPs) obtained by electric stimulation onto periphery nerves were registered in the corresponding central nervous system (CNS) areas. Rats implanted with the biomaterials showed a successful recovery compared with the non-implanted rats after 30days. Lysozyme, derived from egg whites, was used for in vitro assays. This study serves as the basis for testing the biodegradability of the hydrogels (CTS-g-GMA)-X that is promoted by enzymatic hydrolysis. Hydrogels' hydrolysis was studied via lysozyme kinetics at two pH values, 5 and 7, under mechanical agitation at 37°C. Results show that our materials' hydrolysis is slower than pure CTS possibly due to the steric hindrance imposed by the GMA grafting of functionalization. This hydrolysis helps degrade the biomaterial and at the same time it provides support for spinal cord recovery. Combination of these results may prove useful in the use of these hydrogels as scaffolds for cells proliferation and their application as implants in living organisms.

[1]  Nazirah Hasnan,et al.  International Perspectives on Spinal Cord Injury , 2013 .

[2]  J. Wrathall,et al.  Spinal cord contusion in the rat: Production of graded, reproducible, injury groups , 1985, Experimental Neurology.

[3]  E. Kumamoto,et al.  Actions of noradrenaline on substantia gelatinosa neurones in the rat spinal cord revealed by in vivo patch recording , 2004, The Journal of physiology.

[4]  R. J. Dumont,et al.  Acute Spinal Cord Injury, Part I: Pathophysiologic Mechanisms , 2001, Clinical neuropharmacology.

[5]  G. Viniegra-González,et al.  Criteria for the selection of strains of entomopathogenic fungi Verticillium lecanii for solid state cultivation , 2002 .

[6]  M. Shoichet,et al.  Controlling cell adhesion and degradation of chitosan films by N-acetylation. , 2005, Biomaterials.

[7]  A. Domard,et al.  Chitosan: Structure-Properties Relationship and Biomedical Applications , 2001 .

[8]  M. Schwab.  Repairing the Injured Spinal Cord , 2002, Science.

[9]  M. Schwab,et al.  Degeneration and regeneration of axons in the lesioned spinal cord. , 1996, Physiological reviews.

[10]  M. Rinaudo,et al.  The viscosity dependence on concentration, molecular weight and shear rate of xanthan solutions , 1985 .

[11]  G. Gooday.  Physiology of microbial degradation of chitin and chitosan , 1990, Biodegradation.

[12]  A. Pühler,et al.  Xanthan gum biosynthesis and application: a biochemical /genetic perspective , 1998, Applied Microbiology and Biotechnology.

[13]  S. Daduang,et al.  Purification, characterization and comparison of reptile lysozymes. , 2006, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[14]  M. Kasaai,et al.  Intrinsic viscosity–molecular weight relationship for chitosan , 2000 .

[15]  I. Sanchez,et al.  Synthesis and characterization of a hybrid (chitosan-g-glycidyl methacrylate)–xanthan hydrogel , 2013, Journal of biomaterials science. Polymer edition.

[16]  K. Marsh,et al.  Characteristics of Different Molecular Weight Chitosan Films Affected by the Type of Organic Solvents , 2002 .

[17]  C. Taylor,et al.  The distribution of muramidase (lysozyme) in human tissues. , 1975, Journal of clinical pathology.

[18]  W. Park,et al.  Blood compatibility and biodegradability of partially N-acylated chitosan derivatives. , 1995, Biomaterials.

[19]  S. Desobry,et al.  Mechanical and barrier properties of sodium caseinate–anhydrous milk fat edible films , 2004 .

[20]  T. Chandy,et al.  Chitosan--as a biomaterial. , 1990, Biomaterials, artificial cells, and artificial organs.

[21]  Alan R. Johnson,et al.  REGENERATION IN THE VERTEBRATE CENTRAL NERVOUS SYSTEM: PHYLOGENY, ONTOGENY, AND MECHANISMS , 1995, Biological reviews of the Cambridge Philosophical Society.

[22]  S. Woerly,et al.  Spinal cord repair with PHPMA hydrogel containing RGD peptides (NeuroGel). , 2001, Biomaterials.

[23]  C. Zucchini,et al.  Wound management with N-carboxybutyl chitosan. , 1991, Biomaterials.

[24]  M. Matsumoto,et al.  Enzymatic hydrolysis reaction of water-soluble chitin derivatives with egg white lysozyme , 1997 .

[25]  H. Winn,et al.  Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up: Results of the third National Acute Spinal Cord Injury Randomized Controlled Trial , 1998 .

[26]  K. Khwaldia,et al.  Properties of sodium caseinate film-forming dispersions and films. , 2004, Journal of dairy science.